| Title |
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple MyelomaAddressing BCMA Escape with Dual-Targeted CAR T-cell Therapy
|
|---|---|
| Published in |
Blood Cancer Discovery, July 2020
|
| DOI | 10.1158/2643-3230.bcd-20-0020 |
| Pubmed ID | |
| Authors |
Carlos Fernández de Larrea, Mette Staehr, Andrea V. Lopez, Khong Y. Ng, Yunxin Chen, William D. Godfrey, Terence J. Purdon, Vladimir Ponomarev, Hans-Guido Wendel, Renier J. Brentjens, Eric L. Smith |
X Demographics
The data shown below were collected from the profiles of 152 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 56 | 37% |
| Spain | 17 | 11% |
| United Kingdom | 5 | 3% |
| India | 3 | 2% |
| Argentina | 2 | 1% |
| Mexico | 2 | 1% |
| Thailand | 2 | 1% |
| Chile | 2 | 1% |
| Italy | 1 | <1% |
| Other | 13 | 9% |
| Unknown | 49 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 90 | 59% |
| Scientists | 28 | 18% |
| Practitioners (doctors, other healthcare professionals) | 25 | 16% |
| Science communicators (journalists, bloggers, editors) | 8 | 5% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 123 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 35 | 28% |
| Student > Ph. D. Student | 12 | 10% |
| Student > Bachelor | 9 | 7% |
| Student > Master | 6 | 5% |
| Student > Doctoral Student | 5 | 4% |
| Other | 12 | 10% |
| Unknown | 44 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 25 | 20% |
| Agricultural and Biological Sciences | 14 | 11% |
| Immunology and Microbiology | 13 | 11% |
| Medicine and Dentistry | 13 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 9 | 7% |
| Unknown | 46 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 109. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2024.
All research outputs
#391,063
of 25,734,859 outputs
Outputs from Blood Cancer Discovery
#10
of 212 outputs
Outputs of similar age
#12,180
of 432,312 outputs
Outputs of similar age from Blood Cancer Discovery
#1
of 19 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 212 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,312 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.